Impact of the presence of serum neutralising antibodies on recruitment into experimental rhinovirus infection studies in asthmatic subjects

S. Field, R. Pestridge, J. Roberts, V. Tear, C. Boxall, P. Monk (Southampton, United Kingdom)

Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Session: Viruses and respiratory infections: prevalence and mechanisms of infection
Session type: E-Communication Session
Number: 3390
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Field, R. Pestridge, J. Roberts, V. Tear, C. Boxall, P. Monk (Southampton, United Kingdom). Impact of the presence of serum neutralising antibodies on recruitment into experimental rhinovirus infection studies in asthmatic subjects. Eur Respir J 2009; 34: Suppl. 53, 3390

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infection
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011

MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012

Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Preclinical development of an IL-13 neutralising antibody, CAT-354, for the treatment of human asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005

Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Effects of anti-M1 prime monoclonal antibody, MEMP1972A following allergen challenge in patients with mild asthma
Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD
Year: 2012

A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006


The content of IgE and circulating immune complexes (CIC) in pregnant women with exacerbation of chronic simple bronchitis due to cytomegalovirus infection
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


The prevalence of specific SARS IgG in different human group
Source: Eur Respir J 2005; 26: Suppl. 49, 597s
Year: 2005

Detection of IgG and IgE-abs to herpesviruses in asthmatic patients
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009

Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010

High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

Study to determine reference ranges for specific serum IgG against antigens implicated in hypersensitivity pneumonitis in Singapore
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

Attenuation of specific IgE at high allergen exposure is associated with the presence of inhibitory antibodies in laboratory animal allergy
Source: Annual Congress 2009 - High molecular sensitisers and biological dusts
Year: 2009

The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Treatment with omalizumab (rhuMAb-E25), a monoclonal anti-IgE antibody induces effective changes in subjects with allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 37s
Year: 2001

Detection of Mycoplasma pneumoniae IgA and IgM antibodies in adult patients hospitalized because of acute asthma exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004

Evaluation of bronchial hyperreactivity and other functional parameters in severe asthma patients treated with anti-interleukin-5 monoclonal antibody (IL5)
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019